Outpatient Follow-up and Secondary Prevention for Melanoma Patients

Health care providers and their patients jointly participate in melanoma prevention, surveillance, diagnosis, and treatment. This paper reviews screening and follow-up strategies for patients who have been diagnosed with melanoma, based on current available evidence, and focuses on methods to assess...

Full description

Bibliographic Details
Main Authors: Gamble, Ryan G., Jensen, Daniel, Suarez, Andrea L., Hanson, Anne H., McLaughlin, Lauren, Duke, Jodi, Dellavalle, Robert P.
Format: Online
Language:English
Published: Molecular Diversity Preservation International 2010
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835125/
id pubmed-3835125
recordtype oai_dc
spelling pubmed-38351252013-11-21 Outpatient Follow-up and Secondary Prevention for Melanoma Patients Gamble, Ryan G. Jensen, Daniel Suarez, Andrea L. Hanson, Anne H. McLaughlin, Lauren Duke, Jodi Dellavalle, Robert P. Review Health care providers and their patients jointly participate in melanoma prevention, surveillance, diagnosis, and treatment. This paper reviews screening and follow-up strategies for patients who have been diagnosed with melanoma, based on current available evidence, and focuses on methods to assess disease recurrence and second primary occurrence. Secondary prevention, including the roles of behavioral modification and chemoprevention are also reviewed. The role of follow-up dermatologist consultation, with focused physical examinations complemented by dermatoscopy, reflectance confocal microscopy, and/or full-body mapping is discussed. Furthermore, we address the inclusion of routine imaging and laboratory assessment as components of follow-up and monitoring of advanced stage melanoma. The role of physicians in addressing the psychosocial stresses associated with a diagnosis of melanoma is reviewed. Molecular Diversity Preservation International 2010-06-07 /pmc/articles/PMC3835125/ /pubmed/24281112 http://dx.doi.org/10.3390/cancers2021178 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Gamble, Ryan G.
Jensen, Daniel
Suarez, Andrea L.
Hanson, Anne H.
McLaughlin, Lauren
Duke, Jodi
Dellavalle, Robert P.
spellingShingle Gamble, Ryan G.
Jensen, Daniel
Suarez, Andrea L.
Hanson, Anne H.
McLaughlin, Lauren
Duke, Jodi
Dellavalle, Robert P.
Outpatient Follow-up and Secondary Prevention for Melanoma Patients
author_facet Gamble, Ryan G.
Jensen, Daniel
Suarez, Andrea L.
Hanson, Anne H.
McLaughlin, Lauren
Duke, Jodi
Dellavalle, Robert P.
author_sort Gamble, Ryan G.
title Outpatient Follow-up and Secondary Prevention for Melanoma Patients
title_short Outpatient Follow-up and Secondary Prevention for Melanoma Patients
title_full Outpatient Follow-up and Secondary Prevention for Melanoma Patients
title_fullStr Outpatient Follow-up and Secondary Prevention for Melanoma Patients
title_full_unstemmed Outpatient Follow-up and Secondary Prevention for Melanoma Patients
title_sort outpatient follow-up and secondary prevention for melanoma patients
description Health care providers and their patients jointly participate in melanoma prevention, surveillance, diagnosis, and treatment. This paper reviews screening and follow-up strategies for patients who have been diagnosed with melanoma, based on current available evidence, and focuses on methods to assess disease recurrence and second primary occurrence. Secondary prevention, including the roles of behavioral modification and chemoprevention are also reviewed. The role of follow-up dermatologist consultation, with focused physical examinations complemented by dermatoscopy, reflectance confocal microscopy, and/or full-body mapping is discussed. Furthermore, we address the inclusion of routine imaging and laboratory assessment as components of follow-up and monitoring of advanced stage melanoma. The role of physicians in addressing the psychosocial stresses associated with a diagnosis of melanoma is reviewed.
publisher Molecular Diversity Preservation International
publishDate 2010
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835125/
_version_ 1612029136091480064